Scientia Advisors a Life Science Strategy Consulting Firm Will Host Breakfast Series on Personalized Medicine, February 29th 2008

Cambridge, MA, January 22, 2008 --(PR.com)-- The rush to provide the $1000 genome, the development of pharmacogenomics, and the increasing challenges to the ‘blockbuster drug model’ have raised the emphasis on personalized medicine within the life science industry. Through the breakfast series, Scientia Advisors will explore the following topics:

· What are the challenges faced when implementing the new paradigm of personalized medicine?
· What are pharmaceutical and biotechnology companies doing today to adapt and what future developments are on the horizon?

Panelists will be:
Dr. Raju Kucherlapati, Scientific Director of Harvard Partners Center for Genetics and Genomics (www.hpcgg.org)

Mara G. Aspinal, President of Genzyme Genetics (www.genzymegenetics.com)

The breakfast series will take place on February 29th, 2008 from 7.30am to 9.00am at 1 Broadway, 5th floor, Cambridge, MA 02142.

Please visit their website (www.scientiaadv.com) for more information and to register for the event.

###